Cointime

Helio Health

company

About

Helio Health is an AI-driven healthcare company that commercializes early cancer detection tests from a simple blood draw.

  • 51 - 100

Highlights

Total Funding Amount
$118M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$118M
Industries
Artificial Intelligence,Biotechnology,Health Care,Medical
Founded date
Jan 1, 2014
Number Of Employee
51 - 100
Operating Status
Active

Helio Health is an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw. The company’s mission is to simplify cancer screening so lives can be saved by detecting cancer earlier. With Helio’s AI-driven technology, both physicians and their patients gain powerful insights from accurate, accessible, and convenient blood tests. Helio’s development program is focused on liver, colon, breast and lung cancer. Helio Health is headquartered in Irvine, CA, with R&D, GMP and CLIA facilities in Irvine, CA and West Lafayette, IN.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$118M
Helio Health has raised a total of $118M in funding over 2 rounds. Their latest funding was raised on Jul 15, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 15, 2021 Series B $118M 1 Samsung Securities — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Helio Health is funded by 1 investors. Samsung Securities are the most recent investors.
Investor Name Lead Investor Funding Round
Samsung Securities Yes Series B
Cointime
İçerikler
Şirket.